drug discovery and development for the treatment and ... · animal model of filariasis:...

16
IMMIP, Bonn Sabine Specht, Achim Hoerauf NPIMR, Northwick Park Simon Townson Muséum National d’Histoire Naturelle de Paris Coralie Martin Drug discovery and development for the treatment and control of filariasis: repurposing emodepside DNDi Robert Don Ivan Scandale

Upload: hadieu

Post on 07-May-2019

213 views

Category:

Documents


0 download

TRANSCRIPT

IMMIP, Bonn Sabine Specht, Achim Hoerauf NPIMR, Northwick Park Simon Townson Muséum National d’Histoire Naturelle de Paris Coralie Martin

Drug discovery and development for the treatment and control of filariasis: repurposing emodepside

DNDi Robert Don Ivan Scandale

Emodepside (+ praziquantel) is used in topical solutions

Animal Model of filariasis: Litomosoides sigmodontis

• Litomosoides sigmodontis is transmitted by a mite, Onithonyssus bacoti.

• The parasitized mite transmits third stage larvae (L3) during a blood-meal

• The larvae then migrate from the skin, through the lymphatics, to the thoracic (pleural) cavity where they mature and breed.

• The adult female worms release their microfilariae in the pleural cavity from where they make their way to the blood circulation, ready to be taken up by a mite feeding on the skin.

The only fully permissive model for filarial infections

Final host intermediate host

Adult 28 days Release of MF

55-60 days

L3 L2

L4

Ad

L1

In vitro efficacy: microfilariae

Minimum inhibitory concentration (MIC) = 0.1 µM (∼112 ng/ml) MIC is defined as the minimum concentration producing 100%

reduction of motility

Microfilariae L. sigmodontis Microfilariae A. viteae

MIC for L. sigmodontis adult worms is below 0.1 µM (∼112 ng/ml) (minimum concentration producing 100% reduction of motility)

MIC for O. gutturosa adult worms was measured at 0.048 µM (S. Townson et al. ASTMH 54th annual meeting 2005 abstract 280)

In vitro efficacy: adult worms

M T T A s s a y

1 0 µ M 1 µ M 0 .1 µ M 0.01 µ M 1 0% D M S O H e a t0 .0

0 .2

0 .4

0 .6

OD

550

nm

E m o d e p s i de

Adult worm L. sigmodontis

D0 3 months pi

9-12 weeks pt

Natural infection

Treatment‘s start

Worm recovery & analysis

Analysis: - parasite numbers - length of females/males - microfilariae counts

Patency

Randomization (weight, MF)

L4

Ad

L1

Jird model of filariasis: Litomosoides sigmodontis in jird

Exposure in jird

MIC

Dose mg/kg 12.5 25 70

formulation Suspension 2% Cremophor EL in saline

Cmax (ng/mL) 59 58.6 145

Tmax (h) 2 2.33 3.33

T1/2(h) 22 22 19.7

AUC0-last (ng·h/mL) 567 567 2097

(70 mg/kg)

unt re

a ted

0 0m

g /kg

3d

O 50m

g /k g

O 25m

g/kg

1 2 ,5mg/k

g

0

50

1 00

1 50

num

be

r o

f w

orm

sN

b of

reco

vere

d ad

ult w

orm

s

control

X = animals dead after treatment

3x100 5x50 5x25 5x12.5 mg/kg

Jirds infected with L. sigmodontis

100 mg/kg (3 days)

50 mg/kg (5 days)

25 mg/kg (5 days)

12.5 mg/kg (5 days)

Reduction of adult worms compare to control group 55 % 86 % 22 % 0 %

Formulation Suspension in 2% Cremophor EL Route of administration Oral gavage Readout 9 weeks post treatment

M ic rofila re m ia

Be fore

A fter

0 .1

1

1 0

1 0 0

10 0 0

1 00 0 0

MF

/10

µl

9 9 % r e d u c t io n

5 x 50 mg/kg dose : Cmax = 145 ng/mL AUC0-last = 2097 ng·h/mL

5 x 100 mg/kg dose was not tolerated

*

* = P< 0.05

Adult worms

Efficacy in Jird

Exposure in jird

1

10

100

1000

10000

100000

0 4 8 12 16 20 24

Con

cent

ratio

n (n

g/m

L)

Time (h)

Mean Plasma Concentration of Emodepside after PO Administration at 10 mg/kg

Mean PO2

Mean PO5

MIC

Dose mg/kg 10 10

formulation clear solution 25% Capmul MCM in Corn oil

suspension 10% EtOH/40% Solutol/50% H2O

Cmax (ng/mL) 530 195

Tmax (h) 5 1.67

T1/2(h) 14 21.9

AUC0-last (ng·h/mL) 7390 2612

V e h ic le F B Z 2 m g /k g s c E M O 5 d S E M O 1 0 d S E M O 5 d C E M O 1 0 d C0

50

1 00

1 50

2 00

num

be

r o

f w

orm

s

control FBZ sc 5x2 5x10 10x10 5x10 mg/kg

Nb

of re

cove

red

adul

t wor

ms

10x10

M ic rofila rem ia

B efor e

2 4 h pt

4 wks p

t

8 wk s p

t0

5 00 0

1 0 00 0

1 5 00 0

V e h ic leF B Z 2 m g /kg s cE M O 5 d SE M O 1 0 d SE M O 5 d CE M O 1 0 d C

MF

/10

µl

Jirds infected with L. sigmodontis

5 mg/kg (5 days)

10 mg/kg (10 days)

5 mg/kg (5 days)

10 mg/kg (10 days)

Reduction of adult worms compare to control group 82.9 80.8 89.7 72.8

Route of administration Oral gavage Readout 9 weeks post treatment

40% Solutol suspension

25% Capmul solution

Adult worms

* * * *

The excipient Capmul MCM was not well tolerated in jirds

Treatment duration comparison

* = P< 0.05

Conclusions

Exposure of emodepside depends on the formulation

Reduction > 80% of adult worms is obtained when plasma

levels are close to the in vitro MIC (∼ 112 ng/ml); fulfills efficacy TPP requirements for a macrofilaricide

Longer treatment regimens don't seem to improve the pharmacological response

D0 30 days pi

Treatment start 75 days pt

Natural infection

Begin of treatment

Worm recovery & analysis

Analysis: parasite numbers

length of females/males microfilariae counts

Patency

Randomization (weight, MF)

L4

Ad

L1

Murine model of filariasis: Litomosoides sigmodontis in mouse

u n tre atedE M O 2 5m g /kgE MO 12 ,5 m g/kgE MO 1m g /kg0

2 0

4 0

6 0

8 0

control 5x25 5x12.5 5x1 mg/kg

Nb

of re

cove

red

adul

t wor

ms

Mice infected with L. sigmodontis

25 mg/kg (3 days)

12.5 mg/kg (5 days)

1 mg/kg (5 days)

Reduction of adult worms compare to control group 73 % 82 % 72 %

Formulation Solution 100% capmul MCM Route of administration Oral gavage Readout 75 days post treatment

5 x 50 mg/kg dose was not tolerated

5 x 25 mg/kg was partially tolerated: 2 animals died

Linearity of the pharmacokinetic profile allows extrapolating key PK parameters for 1 mg/kg dose: Cmax = 84 ng/ml

AUC0-last = 1399 ng·h/ml

Adult worms

* * *

* = P< 0.05

Efficacy in mice

Exposure in mouse

MIC

Dose mg/kg 6 12.5 25 50

formulation 100% Capmul MCM clear solution

Cmax (ng/mL) 508 1038 1553 3093

Tmax (h) 12 5.33 20 12

T1/2(h) ND 35.1 ND ND

AUC0-last (ng·h/mL) 8396 16354 25775 53594

Conclusion

Comparable efficacy was obtained at all tested doses (25, 12.5 and 1 mg/kg) Reduction of adult worms is about 80%

Exposure of emodepside depends on the formulation PK parameters of efficacious doses in both mouse and the jird

model are approximatively in the same ballpark: Mouse

1 mg/kg (capmul solution) Cmax = 84 ng/ml AUC0-last = 1399 ng·h/ml

Jird 10 mg/kg (solutol suspension) Cmax = 195 ng/ml AUC0-last = 2612 ng·h/ml

THANK YOU

IMMIP Sabine Specht NPIMR Simon Townson Muséum National d’Histoire Naturelle de Paris Coralie Martin

DNDi Robert Don Ivan Scandale